Bone morphogenetic protein (BMP) signaling is critical for germline establishment during mouse embryogenesis. To exploit its importance for induction of germline precursors in vitro, mouse embryonic stem cells (mESCs) were cultured as embryoid body (EB) aggregates with combinations of BMP2, BMP4, and BMP8B for 3-10 days. At Day 10 of culture, well-delineated clusters of POU5F1-positive (POU5F1+) cells were visible in BMP4-treated and BMP2-treated EBs; these were rarely detected in untreated and BMP8B-treated cultures. Quantitative mRNA analysis revealed that a significant elevation of markers associated with primordial germ cell development had occurred in the presence of BMP4 by Day 10, including late germline markers such as Ddx4 (Mvh). Reasoning that germline specification was established by Day 10, we surveyed earlier time points for altered levels of germline marker mRNAs. A peak of early markers, Prdm1 (Blimp1), Ifitm3 (Fragilis), and Dppa3 (Stella), was measured in Day 3 to Day 4 EBs grown in BMP4, followed by a decrease at Day 5. In contrast, other markers, Pou5f1, Nanog, Dazl, and Ddx4, progressively increased from Day 3 to Day 5. Transforming growth factor beta superfamily signaling components Acvr1 (ALK2), Smad1, and Smad5 remained relatively constant. Isolated POU5F1+ cells from BMP4-treated Day 5 EBs contained significantly elevated germline markers compared with POU5F1-negative cells, with a transcript profile differing from mESCs, verifying their unique identity. These results demonstrate that signaling by BMP2 and BMP4, but not BMP8B, enhances germline marker expression within EBs and identify Day 3 to Day 5 in EB differentiation as a window for specification of germ cells in vitro.
INTRODUCTION
Germline specification is one of the earliest cell fate decisions made in the mammalian embryo. Evidence from knockout and ex vivo studies has demonstrated that the initiation of primordial germ cell (PGC) specification is critically reliant on signaling by bone morphogenetic protein (BMP) 2 [1, 2] , BMP4 [3, 4] , and (to a lesser extent) BMP8B [5, 6] . BMP4 and BMP8B are released from the extraembryonic ectoderm, and visceral endoderm cells produce BMP2. These activate the ACVR1 (Alk2) serine-threonine kinase receptor located on adjacent visceral endoderm cells [3] . ACVR1 activation induces phosphorylation and subsequent nuclear translocation of SMAD1, SMAD5, and SMAD8 transcription factors, which enables modulation of target gene expression [3, 7] . These events generate as yet undefined signals that direct a small group of proximal epiblast cells to enter the germ lineage [3, 7] .
Cells competent to form the germline exhibit a specific and essential pattern of gene expression. Blimp1 (Prdm1) and the related Prdm14 are the earliest known markers of the germ lineage in vivo, and they are required for PGC specification [8, 9] . PRDM1 functions in multiple lineages during embryogenesis and serves as a transcriptional repressor in PGCs, acting to suppress the somatic cell program. Transcription from this locus is first detected in approximately six cells of the murine posterior proximal epiblast at Embryonic Day (E) 6.25. These develop into a defined cluster of 20 cells within the posterior proximal epiblast by E7.25 [8] . Fragilis (Ifitm3) mRNA is subsequently upregulated [10] , and initiation of Stella (Dppa3) expression by E7.5 marks the classic founder PGC population of 40 cells [10] . The pluripotency-associated transcription factors Pou5f1 [11] and Nanog [12, 13] are initially expressed throughout the inner cell mass but become restricted to the germline between E7.75 and E8.5. The PGC population then enters a period of proliferation and undergoes both passive and active migration toward the gonads [14] . Once PGCs reach the gonads, germline-specific markers essential for the continued development of the germ cells, including Ddx4 (E10.5-E12.5 [15] ) and Dazl (E11.5 [16] ), are transcribed.
Several technically elegant studies have provided information regarding the temporal sequence of genes expressed during embryonic germline determination. However, future analysis of the signaling pathways involved, delineation of responses to these, and how germline specification and early development may be disrupted might be more readily accomplished with a more accessible system such as in vitro germline genesis.
Embryonic stem cells (ESCs) are derived from the inner cell mass of the blastocyst before germline specification [17] , and their directed differentiation into multiple lineages has been reported [18, 19] . Notably, cultured epiblast cells already exhibit certain germ cell characteristics, including the expression of markers that distinguish them from their epiblast progenitors [20] . Several studies have reported approaches to the generation of germ cells from ESCs in vitro, including spontaneous differentiation in the absence of leukemia inhibitory factor [21] or culturing as embryoid bodies (EBs) [22] . More directed approaches have involved ESC exposure to testis cell-conditioned media [23] or to retinoic acid for extended periods [22, 24, 25] . Culture of ESCs with the germline lineage-inducing ligand BMP4 has been reported to generate germ cell-like cells from both mouse [26] and human [27] ESCs. While this group of studies has shown that it is possible to derive germline cells from ESCs, specification rates are low, and viable offspring [24] exhibit significant developmental abnormalities.
We adopted the strategy of exposing mouse ESCs (mESCs) to a microenvironment mimicking that encountered by cells of the proximal epiblast in vivo [26] . Embryoid body development mirrors certain spatiotemporal aspects of embryonic development [28] , including the development of visceral endoderm [29] . Because multiple cell types (extraembryonic ectoderm, visceral endoderm, and epiblast) are required to express, transduce, and respond to specific BMP pathways to effect PGC specification in vivo, mESCs were aggregated and allowed to differentiate as EBs, with the expectation that this could provide the required cellular mix. When exogenous BMP4 (to mimic extraembryonic ectoderm expression) or BMP2 (with or without BMP8B) was added to the cultures, germline markers Pou5f1, Nanog, Ddx4, and Dazl were detected at significantly higher levels than in cultures to which no exogenous growth factor had been added. These cultures also exhibited an early transient increase in the expression of Prdm1, Dppa3, and Ifitm3, consistent with the absolute requirement for their transcription during the initiation of germline specification in vivo. Cells derived from BMP4-treated EBs can be isolated that exhibit a transcriptional profile consistent with germline specification.
MATERIALS AND METHODS

ESC Culture and EB Differentiation
W9.5 mESCs (courtesy of Paul Hertzog, Monash University) were cultured at 378C in 5% CO 2 in air on mitomycin C-inactivated murine embryonic fibroblasts (MEFs) in ESC medium (Dulbecco modified Eagle medium/20% ESC fetal calf serum, 0.1% nonessential amino acids, 2 mM glutamate, penicillin/streptomycin [all from Gibco, Gaithersburg, MD]), 0.1 mM bmercaptoethanol (Sigma, St. Louis, MO), and 1000 U/ml of ESGRO (Gibco). Before RNA extraction, EB formation, or immunocytochemistry, the mESCs were MEF depleted and replated overnight on 0.1% gelatine-coated tissue culture plastic (Nunc, Rochester, NY). For EB formation and differentiation, ESCs were trypsinized, counted, and diluted to 10 000 cells/ml in ESC medium without leukemia inhibitory factor. Embryoid bodies were formed as 3-ll hanging-drop cultures on inverted bacterial Petri dishes. An ESC line containing the POU5F1 distal enhancer-promoter-enhanced green fluorescent protein (EGFP) reporter [30] (a gift from Jennifer Nichols, University of Cambridge, Cambridge, England) was used to analyze live-cell differentiation responses to the presence and absence of growth factors. This cell line was received and grown on gelatine alone. All other manipulations were as already described. Human recombinant BMP2, BMP4, and BMP8B (R&D Systems, Inc., Minneapolis, MN) were added to the diluted mESCs before hanging-drop formation. To generate the EGFP-positive (EGFPþ) cell line derived from BMP4-treated EBs, Day 10 EBs were dissociated with TryplEx (Gibco) and plated onto gelatine-coated six-well tissue culture dishes (Nunc) in ESC medium and 1000 U/ml of ESGRO. EGFPþ cells were progressively enriched by serial passage (normally three to five passages) until no differentiated cells (EGFP negative [EGFPÀ] ) remained in the culture.
Fluorescence Analysis and Immunocytochemistry
Live-cell imaging of EGFP expression in mESCs and EBs was performed using a Leica (Wetzlar, Germany) MZFLIII upright microscope either under brightfield or with a GFP filter under fluorescence. ). All antibodies were diluted 1:100 in PBS/0.1% bovine serum albumin (BSA). For mESC immunocytochemistry, cells were washed in PBS, fixed in 3.2% phosphonoformatic acid for 10 min, washed, and then subjected to a 10-min permeabilization step in PBS/0.1% Triton X-100. Nonspecific binding was blocked with 0.1% BSA/5% serum for 1 h, followed by incubation with primary antibody overnight at room temperature. Cells were then washed for 30 min with three changes of PBS and incubated overnight at room temperature with goat anti-mouse biotin-conjugated secondary antibody (1:500 in PBS/0.1% BSA; DAKO Corp., Glostrup, Denmark) and then washed and incubated with streptavidin-conjugated tertiary antibody (1:500 in PBS/0.1% BSA; DAKO Corp.) for 3 h at room temperature. Washed cells were mounted with 4 0 ,6 0 -diamidino-2-phenylindole (Vectorshield; DAKO Corp.). For immunocytochemistry on dissociated EBs, EBs were reduced to single-cell suspension as for flow cytometry and then given the same treatment regimen as already described, with cells pelleted between each step at 2000 rpm for 2 min. Embryoid body whole-mount immunocytochemistry was performed using the same protocol, including 0.1% Triton X-100 at all stages. Antibody binding was detected by conventional fluorescence microscopy on a Leica MP560 inverted microscope using a GFP or Texas Red filter or by confocal microscopy on an Olympus (Tokyo, Japan) Fluoview inverted microscope.
Flow Cytometry
EBs were dissociated to single cells in TryplEx (Gibco) and then subjected to flow cytometry (FACSCanto II; Becton-Dickinson, Mountain View, CA). EGFP fluorescence was determined using a 530/30-nm band-pass filter, and results were analyzed using Becton-Dickinson FACSDiva software. The proportions of EGFPþ cells generated under different growth factor and/or time course conditions were compared, as indicated in the appropriate figure legends, and the data were statistically analyzed by paired one-tailed Student ttest using GraphPAD (San Diego, CA) Prism software. Analyzer used the following conditions: denaturation at 958C for 10 min and 40 cycles of amplification at 958C for 30 sec, 628C for 30 sec, and 728C for 30 sec. Each PCR sample was measured in triplicate, and melting-curve analysis monitored PCR product accumulation. All amplified products were verified once by sequencing. To correlate the crossing points from the sample amplification plot with the target mRNA copy number, a standard curve was generated for each product in every experiment using cDNA containing the target gene. The amounts of Rn18s and Gapdh mRNA were measured in each sample template to enable normalization for sample loading of target gene values between samples. Normalization to both of these housekeeper genes gave similar trends in target gene expression between different treatment groups; thus, all Q-PCR results presented represent target gene normalization to Rn18s levels. For statistical analysis, the data were log transformed and analyzed by paired one-tailed Student t-test to compare individual genes under untreated vs. growth factor-treated conditions 
Quantitative PCR Analysis
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FACS for Q-PCR Analysis
Day 5 POU5F1-EGFP EBs (75-80) cultured with BMP4 were dissociated to single cells using TryplEx (Gibco). EGFPþ and EGFPÀ cells were sorted on a MoFlo Analyzer (argon 488-nm laser; DAKO Cytomation, Carpinteria, CA) using Summit version 4.3 software (DAKO Cytomation) and then pelleted by centrifugation (15 min at 6000 rpm). The Q-PCR (300 ng of DNA-free RNA) was performed as already described.
Western Hybridization
Western blots were performed on mESC lysates homogenized at 48C in RIPA buffer (150 mM sodium chloride, 1% Nonidet P-40, 0.5% Tween-20, 0.1% SDS, and 1 mM ethylenediaminetetraacetic acid) in the presence of protease inhibitors (Protease Inhibitor Cocktail Set III; Calbiochem, San Diego, CA) and phosphatase inhibitor (Sigma). Protein concentration was determined (DC protein assay; BioRad, Hercules, CA), and 30 lg per lane was loaded with protein size standards (Page-Ruler Prestained Protein Ladder; Fermentas, Burlington, ON). Proteins were transferred to a Hybond C nitrocellulose membrane (Amersham Biosciences, Paisley, England) and blocked in Odyssey buffer:PBS (1:2) (LI-COR Biosciences, Lincoln, NE). Because the POU5F1 antibody has been extensively described in other publications for example [21] , only the NANOG and DPPA3 antibodies were assayed. NANOG and DPPA3 antibodies (1:1000) were incubated overnight in blocking buffer/0.1% Tween. Alexa Fluor 680-coupled secondary antibodies (Molecular Probes, Eugene, OR) were used at 1:10 000 dilution in blocking solution/0.1% Tween/0.01% SDS. Detection was carried out with the LI-COR Odyssey system.
Bisulfite Sequencing
Genomic DNA was extracted from mESCs, FACS-isolated Day 10 EGFPþ cells, EGFPþ cells with fewer than five passages, or EGFPþ cells with more than 10 passages (as already described) using the Qiagen DNA Mini-Kit.
Genomic DNA from each sample underwent bisulfite treatment, purification, and PCR sequence-specific amplification using the MethylEasy Xceed rapid sodium bisulfite modification kit according to the manufacturer's instructions (Human Genetic Signatures, North Ryde, Australia). Following bisulfite treatment, nested PCRs were performed to amplify the H19 and IGF2R differentially methylated regions (DMRs) using previously published primer sets [31] . Amplified fragments were gel purified using the QIAquick gel extraction kit (Qiagen) and subcloned into the pGemTeasy vector (Clontech, Palo Alto, CA) according to the manufacturer's instructions. Between five and 10 clones from each genomic sample underwent sequencing analysis and were scored for the numbers of methylated and unmethylated CpG dinucleotides.
RESULTS
BMP4 Addition Leads to POU5F1 Expression in Distinct Cell Clusters Within EBs
The addition of appropriate growth factors to EBs during culture can enhance lineage specification [19, 28] , with factor selection based on an understanding of the microenvironment present during normal embryonic development. We applied this approach to pursue PGC specification in vitro based on knowledge of PGC specification in vivo ( Fig. 1A [adapted from de Sousa Lopes et al. [3] ). According to the present model, BMP ligands released from extraembryonic ectoderm cells initiate a signaling cascade that eventually drives PGC specification from a subpopulation of proximal epiblast cells. In our study, POU5F1 was chosen as the primary germline marker because, although it is expressed in both epiblast cells and the ESC population derived from it, POU5F1 synthesis is decreased following differentiation in all lineages except the 392 early germline [32] . We first verified that the EGFP reporter produced an accurate representation of endogenous POU5F1 expression (Fig. 1B) . This was confirmed in mESCs and in EBs grown for 10 days (Fig. 1B and Fig. 3A) . We then tracked POU5F1 expression using fluorescence microscopy in individual EBs treated with and without specific growth factors from Day 3 to Day 10 of culture (Fig. 1C) . At Day 3, EGFP was readily detected in both conditions because of the time required for differentiation of cells within the EB and/or EGFP stability. At Day 5 of culture, EGFP was undetectable in the untreated EBs, while clusters of EGFPþ cells were clearly visible in the BMP4-treated EBs. This was a consistent and robust outcome. Untreated EBs occasionally (,5%) exhibited a similar pattern of positive cell clusters, which is likely because of spontaneous germline specification, as reported previously [22] . However, more than 90% of treated EBs responded to BMP4 addition, as shown. We considered these POU5F1-EGFPþ cells to represent a candidate PGC population.
BMP4 Elicits a Dose-Dependent Biphasic Response in EBs
To determine the efficiency of BMP4 treatment in generating a POU5F1-EGFPþ candidate PGC population, EBs (25 EBs per treatment group) were exposed from the start of culture (Day 0) to a range of BMP4 concentrations (20-500 ng/ml), and the proportion of EGFPþ (POU5F1 expressing) cells was measured at Day 10 by flow cytometry (Fig. 2A) . While the lowest BMP4 concentration led to an 11.7-fold EBs treated with 100 ng/ml or 500 ng/ml of BMP4. Higher concentrations of BMP4 (500 ng/ml) induce the emergence of apparently hemoglobin-positive cells. Arrow indicates a large group of these cells. Original magnification 320.
FIG. 3. Effect of BMPs on EB development.
A) POU5F1-EGFP mESCs were treated from the start of EB culture with either no growth factor (un), 100 ng/ ml of BMP4, 100 ng/ml of BMP8B, 100 ng/ml of BMP4 plus 100 ng/ml of BMP8B. At Day 10 of culture, EBs were labeled by immunofluorescence for detection of endogenous POU5F1 protein, and EBs were visualized using either brightfield (BF) or fluorescence for EGFP expression and endogenous POU5F1. Original magnification 320. B) Flow cytometric measurement of EGFPþ cells in Day 10 EBs treated with 100 ng/ml of each growth factor indicated. At Day 10, 10-15 EBs were dissociated, and the proportion of EGFPþ cells was determined. Untreated (un) sample values were set at 1, and treatment outcomes were recorded as the proportion of EGFPþ cells relative to untreated samples. The proportion of positive cells per treatment is indicated as the average of four experiments. For all analyses, n ¼ 4, and error bars indicate SDs. With the exception of BMP8B, all treatment groups were significantly different relative to untreated samples, with P , 0.001.
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increase in the proportion of EGFPþ cells, the maximal response was observed at BMP4 concentrations of 50 ng/ml (28.3-fold over untreated), 100 ng/ml (27.0-fold), and 200 ng/ ml (28.4-fold). At 500 ng/ml, there was a reduced enhancement (22.4-fold) over untreated cultures relative to the lower doses, as well as an apparent increase in mesodermal lineage specification (Fig. 2B) . The number of clusters at Day 5 of culture in the presence of varying BMP4 concentrations (20-500 ng/ml) was very similar to what was measured at Day 10 (data not shown). Based on the reproducible proportion of POU5F1-EGFPþ cells formed in EBs, 100 ng/ml was chosen as the standard BMP4 dosage.
Effect of BMP Ligands on EB Development
In vivo, both BMP4 and BMP8B produced by the extraembryonic ectoderm are required for optimal PGC specification, and endoderm-derived BMP2 produced in the endoderm is additive with BMP4 in invoking PGC induction [1] . To determine if these growth factors would enhance in vitro germline specification, cells were treated from the start of culture with the following: no growth factor; growth factor BMP2, BMP4, or BMP8B alone; or combinations of these. Live-cell imaging (Fig. 3A) of individual Day 10 EBs and flow cytometry of Day 10 EB groups (Fig. 3B) were used to assess the prevalence of EGFPþ clusters and the proportion of EGFPþ cells. Significant differences were measured in the presence of both BMP2 and BMP4. Whereas 0.4% of cells were EGFPþ in the untreated population, BMP4 treatment alone resulted in a population of 3.3% positive cells. In contrast, BMP8B alone generated an EGFPþ cell proportion similar to untreated EBs (0.3%). There was no significant difference observed between the BMP4 plus BMP8B combination compared with BMP4 alone (3.8%). BMP2 addition yielded a response equivalent to that obtained with BMP4 (3.2%). BMP4 and BMP2 act via the same receptor and downstream signaling pathway; thus, it appears that in this system they are interchangeable. A combination of BMP4 and BMP2 did not result in a higher proportion of POU5F1-EGFPþ cells compared with each factor alone (3.7%). This observed response correlates with the apparent maximal dosage response shown in Figure 2A .
BMP4 Treatment Specifically Elevates Germ Cell Markers
POU5F1-EGFPþ cell clusters were readily detectable in BMP4-treated EBs using measures of live-cell imaging of reporter expression, endogenous protein staining, and flow cytometry. These findings were extended to assess gene expression markers relating to germ lineage development (Fig.  4 [summarized in A and shown in B] ) in addition to established lineage markers for ectoderm, endoderm, and mesoderm and for BMP receptors and signal transducers (Fig. 4C) . Threshold cycle and raw values are given in Supplemental Table S1 (available at www.biolreprod.org). In BMP4-treated EBs cultured for 10 days, Dppa3 was expressed at levels significantly higher than in 
With the exception of Smad1 (P , 0.05), no significant difference was observed in the expression of these markers between the untreated and treated samples. Brachyury was undetectable in both untreated and treated samples. untreated cultures, while the other early germline markers Prdm1 and Ifitm3 did not differ significantly between untreated and BMP4-treated cultures. In contrast, a striking significant difference was observed for Pou5f1 and Nanog. Similarly, the later germ cell markers Ddx4 and Dazl were also expressed at significantly higher levels in EBs cultured with BMP4 compared with untreated EBs. While mRNAs encoding the BMP signaling component Smad5 did not increase in BMP4-treated EBs, both Acvr1 and Smad1 exhibited a small but significant elevation (Fig. 4C) . Neither Nes (ectoderm marker) nor Tty (endoderm marker) was significantly different in the treated cultures, and no T (early mesoderm marker) was detectable at Day 10 ( Fig. 4B) .
BMP4 Treatment Results in the Formation of Clusters of Germline Marker-Positive Cells
The mRNA expression data (Fig. 4) were evaluated and confirmed at the protein level for a subset of germline markers, namely, POU5F1, NANOG, and DPPA3. The NANOG and DPPA3 antibodies were verified by Western hybridization, in which bands of the expected size were detected for NANOG and DPPA3 (Fig. 5A) . Immunofluorescence on undifferentiated mESCs (Fig. 5B) indicated that both NANOG and POU5F1 antibodies were showing the expected nuclear localization for the endogenous proteins, with DPPA3 showing a more cytoplasmic localization. Clusters of cells positive for POU5F1, NANOG, and DPPA3 proteins were readily detectable in EBs treated with BMP4 but were extremely rarely detected in untreated EBs of the same age (Fig. 5C ). The difficulty in detecting germline marker-positive cells in untreated EBs by this approach was because of a combination of the significantly lower numbers present compared with those in treated EBs (determined by marker expression and flow cytometry) and the scanning depth limitations of confocal scanning laser microscopy (CSLM); thus, it is not indicative of a complete absence of these cells. Endogenous POU5F1 and a fourth germline marker, FUT4, were also detected only in those cells expressing POU5F1-EGFP in dissociated BMP4-treated EBs ( Fig. 5D and Supplemental Fig. S1B ).
BMP4-Treated EBs Maintain a Consistent Proportion of POU5F1þ Cells up to Day 10
At Day 10, the POU5F1 population can be readily distinguished through visualization of the EGFP reporter. To more precisely define the timing of germline allocation within BMP4-treated EBs, we first compared the proportions of POU5F1-EGFPþ cells present at Day 5 and Day 10 of culture. At both time points, 3.5% of EB cells (on average) were EGFPþ (Fig. 6A) . Because the EBs continue to expand in size from Day 5 to Day 10, it appears that the population of POU5F1-EGFPþ cells is set at a defined proportion of the total EB cells before Day 5 and is maintained through proliferation.
Differences Between Untreated and BMP-Treated EBs Are Measured at Day 3 of Culture
To determine how early the response to BMP could be detected based on POU5F1-EGFP reporter expression, EBs were treated with either BMP4 alone or with a combination of BMP2, BMP4, and BMP8B. Samples were collected at Day 3, Day 4, and Day 5 for flow cytometry analysis (Fig. 6B) .
FIG. 5. Expression of germline marker proteins in whole-mount BMP4-treated EBs and colocalization of endogenous markers with EGFPþ cells. A) NANOG and DPPA3
antibodies were verified by Western hybridization with mESC lysates. B) POU5F1 and NANOG exhibit nuclear localization in undifferentiated mESCs, while DPPA3 is primarily localized to the cytoplasm. Expression and subcellular localization of POU5F1, NANOG, and DPPA3 proteins were determined by immunofluorescence on undifferentiated mESCs. C) BMP4 treatment leads to formation of readily detectable germline marker-positive clusters in Day 10 EBs. Embryoid bodies, untreated (ÀBMP4) or treated (þBMP4) from the start of culture with 100ng/ml of BMP4, underwent whole-mount immunofluorescence to detect expression of POU5F1, NANOG, and DPPA3 proteins. The CSLM images are shown for two representative BMP4-treated EBs and for one untreated EB. Clusters positive for POU5F1, NANOG, and DPPA3 were readily detected within the 100-lm CSLM scanning depth in BMP4-treated EBs, but positive cells were very rarely detected in untreated EBs. D) Endogenous POU5F1 and FUT4 colocalize with EGFPþ cells. Day 10 BMP4-treated EBs were dissociated and analyzed by immunofluorescence for expression of endogenous POU5F1 and FUT4 (endog.
) in relation to EGFP (POU5F1-EGFP). Endogenous POU5F1 or FUT4 was coexpressed in all EGFPþ cells, while no POU5F1 or FUT4 was evident in EGFPÀ cells. BF, brightfield. Original magnification 360 (confocal [B and C]) and 340 (D).
Although at Day 3 most cells still exhibited EGFP expression, the mean signal in the treated sample population was already lower than in the untreated population. This trend was also evident at Day 4 and Day 5. This suggests that exposure to BMPs drives the overall differentiation of most EB cells faster than spontaneous differentiation occurs in untreated samples. By Day 4 of culture, a small ''shoulder'' subpopulation of cells exhibiting higher EGFP expression was observed (Fig. 6B) . Only 24 hours later, most cells in all samples exhibited low to undetectable EGFP expression, and a distinct EGFPþ population was detectable in BMP-treated samples. The EGFPþ cells represented 3.5% of the total cell population (Fig. 6B) . The combination of all three BMPs elicited a similar response to BMP4 alone at Days 3, 4, and 5 and correlates with the responses observed at Day 10 (as in Fig. 3 ).
Growth Factor Treatment of EBs Induces Expression of Genes Critical for Early PGC Specification
The EB response to BMP treatment is visually detectable using the POU5F1-EGFP reporter by Day 5 of culture and as early as Day 3 by flow analysis. Therefore, we focused on determining whether transcriptional changes had been initiated that would correlate with establishment of germ cells. POU5F1-EGFP mESCs cultured as EBs were collected at Days 3, 4, and 5 for Q-PCR analysis of germline lineage markers. At 3 days of culture with BMP4, the earliest primordial germ lineage markers (Prdm1, Ifitm3, and Dppa3 mRNAs) were detected at significantly higher levels than in untreated samples (Fig. 7A) . These mRNAs displayed a peak of expression at Day 4 and were lower at Day 5. Dppa3 is a germ cell-specific marker, and the concordance of its peak with both Prdm1 and Ifitm3 suggests it is at this stage that specification of the putative germ lineage is occurring. Slightly higher levels of these three markers were measured following culture with the combination of BMP2, BMP4, and BMP8B; however, no difference was observed between the BMP4-only or combination treatment groups by Day 10 (data not shown).
Levels of Pluripotency and Later Germ Cell Markers Increase in BMP4-Treated Cultures Between Day 3 and Day 5
While a significant difference in early germ cell marker expression was recorded at Day 3 in BMP4-treated cultures, Pou5f1, Nanog, Ddx4, and the postmigratory marker Dazl were slightly delayed, first increasing in relative expression at Day 4. All markers continued to increase in relative expression in BMP4-treated cultures between Day 4 and Day 5 (Fig. 7B) . This progressive emergence of germline markers in a pattern that mimics in vivo events suggests that normal germline specification may occur within EBs in these conditions.
Other Lineages and Signaling Markers Are Present but Are Unaffected by BMP4
For BMP signaling to mimic in vivo events, key BMP signaling pathway components are required within the EBs. The mRNAs encoding Acvr1, Smad1, and Smad5 (Fig. 7C) were all detected in EBs, and ACVR1 protein was detected by Error bars indicate the SD. *P , 0.01 for the difference between treated and untreated samples. B) Emergence of the potential PGC population is evident as early as Day 3 of culture. Embryoid bodies were treated from the start of culture with either no growth factor (un), 100 ng/ml of BMP4, or 100 ng/ ml each of BMP2, BMP4, and BMP8B (BMP248b). Ten to fifteen EBs were analyzed at each time point (n ¼ 3). One representative population analysis is shown. By Day 3, the population means of the treated samples showed lower EGFP levels than the untreated samples. At Days 4 and 5, the difference in population means was more pronounced. In addition, the treated EBs at Day 4 exhibited a shoulder population that represented a subpopulation of cells with higher levels of EGFP. By Day 5, the majority of cells no longer contained EGFP, while a clear EGFPþ subpopulation had emerged in the BMP4-treated and BMP248b-treated samples.
immunofluorescence in Day 5 EBs (data not shown). Only
Smad5 exhibited significantly increased expression in the BMP4-treated cultures, but this first appeared at Day 5, after the early germline markers Prdm1, Dppa3, and Ifitm3 had exhibited altered expression. This result is consistent with BMP signaling affecting ACVR1, SMAD1, and SMAD5 at the posttranslational level rather than the transcriptional level [33, 34] .
TGFB ligands, including BMP4, exert pleiotrophic effects on the embryo during development [35] , so selected markers of each of the three somatic lineages were measured. Little to no effect of BMP4 treatment was observed on the levels of either Nes (ectodermal marker) or Tty (endodermal marker) (Fig. 7D) relative to the untreated samples using our approach. The transient increase in the mesodermal lineage marker (T) between Day 3 and Day 4 was consistent with the inductive role of BMP4 previously described for this lineage in similar cultures [36] .
Induction of Germline Markers by BMP4 Treatment Observed in a Second mESC Line
To investigate whether BMP4 addition also elevated germ cell markers in EBs derived from a different mESC line, a replicate analysis was conducted on W9.5 mESCs (Fig. 7E) . Strikingly, the early germ cell marker (Prdm1) was also elevated at Day 4 in this cell line. Also, as observed in POU5F1-EGFP EBs, BMP4-treated W9.5 EBs exhibited an increase from Day 3 to Day 5 of culture in the levels of Pou5f1, Dazl, and Ddx4 compared with untreated EBs, although the GERM CELLS DERIVED FROM EMBRYONIC STEM CELLS magnitude of increase was lower than in the POU5F1-EGFP cell line.
Putative PGCs from BMP-Treated EBs Exhibit an Expression Profile Distinct from mESCs
To test whether the POU5F1-EGFPþ subpopulation in Day 5 EBs was the source of the elevated germline marker mRNAs measured in BMP4-treated whole EBs, we separated this subpopulation from the EGFPÀ cells by FACS to compare their expression profiles by Q-PCR. This approach was also used to test whether the EB-isolated cells were a distinct cell type and not merely pluripotent mESCs maintained within the EB (Fig. 8, A and B) . All of the germ cell markers analyzed exhibited significantly higher expression in the EGFPþ Day 5 EB cells than in the EGFPÀ cells. The early germ cell and pluripotency markers were most highly differential between the two populations, with values ranging from 25.2 6 4.1-fold higher in the EGFPþ cells at the lowest end for Ifitm3 to 221.0 6 47.2-fold at the highest end for Pou5f1. The late germ cell markers Ddx4 and Dazl exhibited less difference between the two subpopulations but were still expressed significantly higher in the EGFPþ cells.
There is a striking difference between the expression levels of both early and late germ cell markers between the EGFPþ cells and mESCs (Fig. 8B) . Levels of the early germ cell markers Prdm1, Ifitm3, and Dppa3 were significantly higher in EGFPþ cells than in the mESC population. There was no EGFPþ BMP4-treated EBs and, along with the EGFPÀ fraction and mESCs, were subjected to Q-PCR. Data are expressed as the mean fold difference 6 SEM (n ¼ 3). Asterisks indicate significant differences between the cell populations (P , 0.05). A) All germ cell markers analyzed exhibited significantly higher expression in the EGFPþ subpopulation than in the EGFPÀ subpopulation. Dppa3, Pou5f1, and Nanog exhibited the greatest difference in relative expression between the EGFPþ and EGFPÀ populations, while late germ cell markers Ddx4 and Dazl were detected at lower relative levels but remained significantly higher in the EGFPþ cells. B) Early germ cell markers Prdm1, Dppa3, and Ifitm3 all exhibited significantly higher levels of expression in the EGFPþ subpopulation relative to expression in ESCs. The pluripotency gene Pou5f1 was expressed at levels similar to mESCs, as was the later germ cell marker Ddx4. While Nanog expression was slightly but significantly lower in the EGFPþ cells than in mESCs, Dazl expression was 10-fold lower than in mESCs. C) EGFPþ cells undergo epigenetic reprogramming only following long-term culture. CpG methylation at the H19 DMR was assessed by bisulfite sequencing in mESCs, Day 10 EGFPþ cells, EGFPþ cells cultured for fewer than five passages (P5), and EGFPþ cells cultured for more than 10 passages. The H19 DMR exhibited extensive methylation (meth) in undifferentiated mESCs (85%), and this appeared unchanged in the Day 10 EGFPþ FACS-isolated PGC population (94%) or EGFPþ cells cultured for fewer than five passages (79%). In contrast, prolonged passages (.10) led to almost complete demethylation (1%) of the H19 DMR. D) Mouse embryonic stem cells treated with BMP4 and differentiated as EBs generate a subpopulation of cells that expresses germline markers. Compared with the progenitor mESCs, this subpopulation exhibits a pattern of expression consistent with PGCs at a developmental stage between migration and colonization. For germline marker references, see Figure 4A . 398 difference in Pou5f1 expression between the two cell types, perhaps reflecting the critical role that POU5F1 has in the maintenance of stemness in both PGCs and mESCs. Nanog was expressed at a lower level in the EGFPþ cells, and Ddx4 mRNA was present at similar levels in both cell types. Of particular note is the observation that the latest germ cell marker tested in this study, Dazl, was expressed at significantly higher levels in mESCs than in the isolated POU5F1-EGFPþ cells.
The EB microenvironment supports PGC specification and differentiation but is not sufficient to induce epigenetic reprogramming of imprinted loci. Methylation of CpG dinucleotides at the H19 (Fig. 8C) 
DISCUSSION
We have mimicked an in vivo physical and biochemical microenvironment in vitro to drive mESCs toward the germline. By allowing mESCs to differentiate from a controlled starting population of approximately 300 cells in hanging drops in an optimized concentration of BMP4, we have revealed a response that closely mimics in vivo gene expression patterns during germline specification. Of particular note are the expression patterns of Prdm1, Ifitm3, and Dppa3, the earliest determinants of the PGC lineage [37] . These showed a transient elevation in a small community of cells, reflecting the known in vivo expression patterns required for germline specification. Delayed increase in the expression of later markers (Pou5f1, Nanog, Ddx4, and Dazl) also indicated that these cells were progressing through an appropriate temporally organized gene expression program. Although the majority of the analyses were performed on the POU5F1-EGFP cell line, two other mESC lines, W9.5 wild type and E14 (E14 data not shown), also displayed increases in Prdm1, Pou5f1, Nanog, Ddx4, and Dazl when treated with BMP4, consistent with the POU5F1-EGFP cell line results presented herein. We were not surprised to observe slight differences in the time line because of strain differences, as there is considerable strain difference exhibited during reproductive development in vivo. Despite this, Days 3-5 appear to be consistently important for in vitro germline differentiation. The effect of BMP4 on mESC differentiation also appears to be independent of serum-derived factors, as under serum-free conditions (in chemically defined media [38] ) POU5F1-EGFP EBs exhibited an increase in EGFPþ cells in response to BMP4 treatment (data not shown).
One challenge faced by researchers attempting to generate PGCs from mESCs is the almost identical gene expression profile of these two cell types, particularly with respect to germline markers [20] . Although both the EB-derived EGFPþ cells and their progenitor ESCs expressed germline markers, significant differences in the expression levels of developmentally critical markers were measured between the two cell types. In our system, while the pluripotency marker Pou5f1 was detected at similar levels in both mESCs and POU5F1-EGFPþ cells within BMP4-treated EBs, the very early germline markers Prdm1, Ifitm3, and Dppa3 were present at significantly higher levels in the EB-derived cells, indicating that PGC specification had been initiated. In addition, while the later germ cell marker Ddx4 was expressed at similar levels in both cell types, Dazl (the latest marker tested) was actually significantly lower in the EB-derived cells than in their ESC progenitors. We suggest that the lowered Dazl expression also demonstrates differentiation from the ESC state and its associated broad expression pattern toward a stage-appropriate PGC. This information is also indicative of the developmental stage to which the putative PGCs generated in EBs had matured (Fig. 8D ), suggesting that they had reached the late migratory stage but had not yet activated markers associated with colonization.
Given this staging and the crucial role of Dazl in PGC development during the imprinting phase and for progression through meiosis [39] , these putative PGCs may not yet be suitable for direct transplantation into the testis or ovary. In addition, precolonization PGCs generate teratomas in approximately 30% of transplanted testes [40] . However, these cells present an ideal model to study the influence of the embryonic gonad on embryonic germ cell development. It is likely that aggregation with embryonic somatic gonadal cells will drive further differentiation of these cells toward a postcolonization stage appropriate for transplantation.
Spontaneous differentiation of cells within EBs into multiple lineages has been described previously [28] , and there is evidence that cells within an EB are capable of spontaneous differentiation into the germline based on marker expression [22] (our data not shown). This appears to occur at a low frequency and takes up to 20 days in culture to manifest at levels detectable by semiquantitative PCR. The inductive capacity of BMP4 is known in vivo and, using a different approach, has previously been shown to influence the emergence of ESC-derived cells expressing germ cell markers [26] . In that study, BMP4 was presented to mESCs as a recombinant protein made by Cos7 cells coaggregated in EBs. It is notable that the proportion of EB cells with putative germline characteristics in the present study (approximately 3%) matches that reported by these authors.
Most important, while the manuscript was in preparation, a study [41] was published describing germline differentiation from ESCs. Taking a similar approach to that presented herein but using different mESC strains, culture media, and EB formation methods, approximately 3% of the BMP4-treated EB cells at Day 4 were reported to be positive for a different PGC marker, Dppa3, compared with approximately 0.8% of cells in untreated EBs. Although the study by Wei et al. [41] did not include a comparative time line of marker expression in untreated and BMP4-treated EBs as presented herein, the expression of Nanog and Prdm1 in progenitor ESCs and EBderived PGCs reported at Day 4 correlates well with our findings at Day 5. Unlike Wei et al., however, we did not observe significant reprogramming of the H19 DMR in Day 10 EB-derived EGFPþ cells when examined using bisulfite sequencing. Considering the apparent developmental stage of the in vitro-derived PGCs, we did not expect to detect significant reprogramming at these sites, as demethylation of imprinted loci in vivo does not occur extensively until after gonad colonization [42] [43] [44] [45] . In contrast, we observed demethylation of the H19 DMR (from 85% to 1%) when EGFPþ cells were isolated from BMP4-treated EBs and cultured through more than 10 passages, suggesting that epigenetic reprogramming of EB-derived PGCs had occurred as a result of prolonged culture rather than as part of the earlier development that had occurred in an appropriate temporal progression within the EB microenvironment. Whether these epigenetic changes correctly mimic normal biological reprogramming remains to be determined; however, it has been suggested that reprogramming of imprinted loci in many PGCs may require input from embryonic gonadal somatic cells [42] , a factor that may explain GERM CELLS DERIVED FROM EMBRYONIC STEM CELLS the difficulty in generating functional germ cells in previous investigations. Despite these differences, it is encouraging that for the first time two independent studies have successfully generated germ lineage-specified cells using similar approaches.
While signaling pathways activated during germline specification in the mouse embryo would normally be initiated by BMP4 secreted from the extraembryonic ectoderm, it appears that BMP2 can substitute for BMP4 in our experimental system. This direct redundancy does not occur in vivo; Bmp4-null mutants do not develop PGCs [4] . However, both BMP2 and BMP4 act via the ACVR1 receptor and activate similar downstream signaling pathways. Similarly, during normal mouse development, signals from BMP4 and BMP8B combine to generate the full complement of PGCs, as determined in knockout [5] and ex vivo [6] analyses. The absence of an increase in the proportion of EGFPþ cells with these combined growth factors may be due to the developmental state of cultured mESCs, as mESCs express germline markers (such as Dppa3 and Ifitm3) that are not present in the inner cell mass or early epiblast. It has been suggested that mESCs may already be partially germline specified [20] ; thus, germline specification in vitro may not require the full complement of growth factors needed in vivo. Alternatively, we (Supplemental Fig. S1A ) and others [46] have shown that BMP8B transcripts are detectable at low levels in ESCs and consequently very early EBs; thus, this factor may provide a level of influence beyond which additional growth factor would not elicit a greater response.
The present study has demonstrated the capacity of BMP4 to selectively generate clusters of POU5F1þ cells with a germline transcriptional profile that is distinct from mESCs. Given the spatial disorganization generally associated with EBs, the appearance of POU5F1þ cells as clusters provides an encouraging indication that a small subset of cells in the early EB can emulate the transduction of BMP4 signaling normally performed by the visceral endoderm in vivo. Such cells would have the potential to induce differentiation of neighboring cells that could eventually manifest as the cluster of cells we observe expressing PGC markers. These clusters of POU5F1-positive cells constitute a target population of readily identifiable cells that can be isolated from the surrounding somatic cells for propagation and further differentiation. In addition, although mouse and human reproductive development differs at many stages, the response measured herein of murine mESCs to exogenous BMP4 is similar to that described for human ESCs [27] , supporting the concept that germline specification occurs through conserved mechanisms. Thus, the approach described in this study could be applied to analysis of early human PGC development. Because it so closely mimics in vivo specification of the germline, our approach to in vitro germline specification offers a model of early germ cell development readily accessible to analysis and manipulation. The cells exhibited a temporal gene expression pattern consistent with early germline specification, which indicates their suitability for studies of germ cellsomatic cell interactions and ultimately for the generation of viable offspring.
